A new buy for my Vrijheid Fonds – AbbVie.
Although we see a lot of all-time highs in the market, we still find some pearls to invest in. And as I’ve already mentioned in an earlier post, I opened an account by a new broker, which has lower fees than my other brokers. I like to invest my money with a fee-maximum of 1% of my invest amount. And lower fees than also means that I need a lower amount of fresh cash to make a new buy.
For me also applies that I’ll rather be on time in the market, then timing the market. And when I find a pearl, I can’t resist to pull my buy trigger. This time I’ve averaged down one of the Dividend Aristocrats I own. This week I made my fourth buy in 2019 for my Vrijheid Fonds.
Last year I did an analysis of AbbVie. If you haven’t read my analysis, please take a look at this post about AbbVie Stock Analysis Polliestyle – 2019.
This week I’ve bought 8 shares of ABBV at $ 78.425 per share (incl. fees).
With this buy I added almost €13 (after taxes) of projected dividend to my Vrijheid Fonds for 2019. Now I own 33 shares of AbbVie and this position produces € 74 ($83) after taxes in dividend income annually.
The projected dividend income for 2019 for my Vrijheid Fonds is €4,031.
Again, a small step in my journey and one-step closer to my goal. Has anyone else invested in this company recently? Any feedback is greatly appreciated!
Disclaimer: I’m not a registered investment adviser, investment professional, brokerage firm or investment company. Readers are advised that information on the website is issued solely for information purposes and not to be construed as an offer or recommendation to buy, hold, or sell any securities. All information, opinions, and analyses included are based on sources believed to be reliable, but no representation or warranty is made concerning accuracy, correctness, timeliness, or appropriateness. Please consult with an investment professional before investing any of your money.